{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T18:13:23Z","timestamp":1788372803286,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.numecd.2021.02.011","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T01:33:23Z","timestamp":1613871203000},"page":"1569-1578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Causal effects of plasma lipids on the risk of atrial fibrillation: A multivariable mendelian randomization study"],"prefix":"10.1016","volume":"31","author":[{"given":"Qi","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingxin","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongping","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lishang","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debing","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xintao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojiao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9844-486X","authenticated-orcid":false,"given":"Minglong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2021.02.011_bib1","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0735-1097(00)01107-4","article-title":"Epidemiology and natural history of atrial fibrillation: clinical implications","volume":"37","author":"Chugh","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2021.02.011_bib2","first-page":"255","article-title":"The epidemiology of atrial fibrillation and stroke","volume":"34","author":"Pistoia","year":"2016","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.numecd.2021.02.011_bib3","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrcardio.2014.118","article-title":"Global epidemiology of atrial fibrillation","volume":"11","author":"Rahman","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.numecd.2021.02.011_bib4","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1161\/CIRCULATIONAHA.118.034978","article-title":"Associations of variability in blood pressure, glucose and cholesterol concentrations, and body mass index with mortality and cardiovascular outcomes in the general population","volume":"138","author":"Kim","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2021.02.011_bib5","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1253\/circj.CJ-11-1134","article-title":"Cholesterol paradox\" in atrial fibrillation","volume":"75","author":"Suzuki","year":"2011","journal-title":"Circ J"},{"key":"10.1016\/j.numecd.2021.02.011_bib6","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1253\/circj.72.909","article-title":"Prevalence of atrial fibrillation in community-dwelling Japanese aged 40 years or older in Japan: analysis of 41,436 non-employee residents in Kurashiki-city","volume":"72","author":"Iguchi","year":"2008","journal-title":"Circ J"},{"key":"10.1016\/j.numecd.2021.02.011_bib7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/CIRCEP.111.966804","article-title":"Blood lipid levels, lipid-lowering medications, and the incidence of atrial fibrillation: the atherosclerosis risk in communities study","volume":"5","author":"Lopez","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.numecd.2021.02.011_bib8","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1161\/CIRCEP.113.001378","article-title":"Paradoxical association of lipoprotein measures with incident atrial fibrillation","volume":"7","author":"Mora","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.numecd.2021.02.011_bib9","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/clc.22864","article-title":"Lipid profile and incidence of atrial fibrillation: a prospective cohort study in China","volume":"41","author":"Li","year":"2018","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.numecd.2021.02.011_bib10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.amjcard.2018.03.024","article-title":"Relation between lipid profile and new-onset atrial fibrillation in patients with systemic hypertension (from the Swedish primary care cardiovascular database [SPCCD])","volume":"122","author":"Mourtzinis","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2021.02.011_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012771","article-title":"Low lipid levels and high variability are associated with the risk of new-onset atrial fibrillation","volume":"8","author":"Lee","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.numecd.2021.02.011_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000006942","article-title":"Cholesterol paradox in patients with paroxysmal atrial fibrillation","volume":"92","author":"Annoura","year":"1999","journal-title":"Cardiology"},{"key":"10.1016\/j.numecd.2021.02.011_bib13","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1253\/circj.CJ-11-0780","article-title":"Association between lipid profile and risk of atrial fibrillation","volume":"75","author":"Watanabe","year":"2011","journal-title":"Circ J"},{"key":"10.1016\/j.numecd.2021.02.011_bib14","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007372","article-title":"Associations of lipoprotein(a) levels with incident atrial fibrillation and ischemic stroke: the ARIC (atherosclerosis risk in communities) study","volume":"6","author":"Aronis","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.numecd.2021.02.011_bib15","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.120.008401","article-title":"Lp(a) (lipoprotein [a]) and risk for incident atrial fibrillation: multi-ethnic study of atherosclerosis","volume":"13","author":"Garg","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.numecd.2021.02.011_bib16","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0002-8703(98)70151-6","article-title":"Elevated serum lipoprotein(a) is a risk factor for left atrial thrombus in patients with chronic atrial fibrillation: a transesophageal echocardiographic study","volume":"136","author":"Igarashi","year":"1998","journal-title":"Am Heart J"},{"key":"10.1016\/j.numecd.2021.02.011_bib17","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007444","article-title":"Dyslipidemia and risk of cardiovascular events in patients with atrial fibrillation treated with oral anticoagulation therapy: insights from the ARISTOTLE (apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation) trial","volume":"7","author":"Pol","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.numecd.2021.02.011_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?","volume":"32","author":"Smith","year":"2003","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.numecd.2021.02.011_bib19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/aje\/kwu283","article-title":"Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects","volume":"181","author":"Burgess","year":"2015","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.numecd.2021.02.011_bib20","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/s41588-018-0171-3","article-title":"Biobank-driven genomic discovery yields new insight into atrial fibrillation biology","volume":"50","author":"Nielsen","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.numecd.2021.02.011_bib21","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.117.309732","article-title":"Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes","volume":"120","author":"Staerk","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.numecd.2021.02.011_bib22","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/ng.3396","article-title":"A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease","volume":"47","author":"Nikpay","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.numecd.2021.02.011_bib23","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41588-018-0058-3","article-title":"Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes","volume":"50","author":"Malik","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.numecd.2021.02.011_bib24","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ng.2797","article-title":"Discovery and refinement of loci associated with lipid levels","volume":"45","author":"Willer","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.numecd.2021.02.011_bib25","doi-asserted-by":"crossref","first-page":"11122","DOI":"10.1038\/ncomms11122","article-title":"Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA","volume":"7","author":"Kettunen","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.numecd.2021.02.011_bib26","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies","volume":"40","author":"Burgess","year":"2011","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.numecd.2021.02.011_bib27","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1093\/ije\/dyx028","article-title":"Two-sample Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique","volume":"45","author":"Hartwig","year":"2016","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.numecd.2021.02.011_bib28","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/ije\/dyx102","article-title":"Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption","volume":"46","author":"Hartwig","year":"2017","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.numecd.2021.02.011_bib29","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.numecd.2021.02.011_bib30","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.numecd.2021.02.011_bib31","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.numecd.2021.02.011_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaa070","article-title":"Plasma lipids and risk of aortic valve stenosis: a Mendelian randomization study","author":"Nazarzadeh","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2021.02.011_bib33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/EDE.0000000000000559","article-title":"Sensitivity analyses for robust causal inference from mendelian randomization analyses with multiple genetic variants","volume":"28","author":"Burgess","year":"2017","journal-title":"Epidemiology"},{"key":"10.1016\/j.numecd.2021.02.011_bib34","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/ije\/dyt179","article-title":"Calculating statistical power in Mendelian randomization studies","volume":"42","author":"Brion","year":"2013","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.numecd.2021.02.011_bib35","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome","volume":"7","author":"Hemani","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.numecd.2021.02.011_bib36","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1194\/jlr.M076232","article-title":"A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms","volume":"58","author":"Mack","year":"2017","journal-title":"J Lipid Res"},{"key":"10.1016\/j.numecd.2021.02.011_bib37","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.amjcard.2013.05.009","article-title":"Validation and quantification of genetic determinants of lipoprotein-a levels and predictive value for angiographic coronary artery disease","volume":"112","author":"Anderson","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2021.02.011_bib38","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1194\/jlr.R067314","article-title":"Structure, function, and genetics of lipoprotein (a)","volume":"57","author":"Schmidt","year":"2016","journal-title":"J Lipid Res"},{"key":"10.1016\/j.numecd.2021.02.011_bib39","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa1905239","article-title":"Lipoprotein(a) reduction in persons with cardiovascular disease","volume":"382","author":"Tsimikas","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2021.02.011_bib40","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13046-019-1511-6","article-title":"Exosomal transfer of miR-15b-3p enhances tumorigenesis and malignant transformation through the DYNLT1\/Caspase-3\/Caspase-9 signaling pathway in gastric cancer","volume":"39","author":"Wei","year":"2020","journal-title":"J Exp Clin Canc Res"},{"key":"10.1016\/j.numecd.2021.02.011_bib41","doi-asserted-by":"crossref","first-page":"426","DOI":"10.4161\/auto.22924","article-title":"Inhibition of autophagy through MAPK14-mediated phosphorylation of ATG5","volume":"9","author":"Hocker","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.numecd.2021.02.011_bib42","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1002\/jcp.29276","article-title":"Upregulation of miR-183 represses neuropathic pain through inhibiton of MAP3K4 in CCI rat models","volume":"235","author":"Huang","year":"2020","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.numecd.2021.02.011_bib43","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nrcardio.2015.2","article-title":"Inflammation and the pathogenesis of atrial fibrillation","volume":"12","author":"Hu","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.numecd.2021.02.011_bib44","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJMoa1500858","article-title":"Efficacy and safety of evolocumab in reducing lipids and cardiovascular events","volume":"372","author":"Sabatine","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2021.02.011_bib45","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41467-019-13690-5","article-title":"Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure","volume":"11","author":"Shah","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.numecd.2021.02.011_bib46","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1093\/bioinformatics\/btz469","article-title":"PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations","volume":"35","author":"Kamat","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.numecd.2021.02.011_bib47","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/CIRCULATIONAHA.118.037184","article-title":"Lipoprotein(a), PCSK9 inhibition, and cardiovascular risk","volume":"139","author":"O'Donoghue","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2021.02.011_bib48","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/sim.3034","article-title":"Mendelian randomization: using genes as instruments for making causal inferences in epidemiology","volume":"27","author":"Lawlor","year":"2008","journal-title":"Stat Med"},{"key":"10.1016\/j.numecd.2021.02.011_bib49","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.neurol.2019.04.010","article-title":"Gene-environment interaction and Mendelian randomisation","volume":"175","author":"Kolber","year":"2019","journal-title":"Rev Neurol (Paris)"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475321000600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475321000600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:18:40Z","timestamp":1760545120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475321000600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0939475321000600"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2021.02.011","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Causal effects of plasma lipids on the risk of atrial fibrillation: A multivariable mendelian randomization study","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2021.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}